Tradeoffs

A bipartisan bill takes aim at a $500 billion health care problem that few people have ever heard of. Will it make care better for some of the country’s sickest, poorest patients?Guests:U.S. Senator Bill Cassidy (R-LA)Saleema Render-Hornsby, Dually eligible patientAllison Rizer, MBA, Executive Vice President, ATI AdvisoryEric Roberts, PhD, Associate Professor, University of Pennsylvania Perelman School of MedicineCasey Schwarz, JD, Senior Counsel, Medicare Rights CenterHong Truong, Caregiver of dually eligible patientLeslie Walker, Senior Reporter, TradeoffsLearn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

There are a lot of concerns about the dangers artificial intelligence could pose to your health privacy. AI expert Nicholson Price explains why he thinks too much concern over privacy could make health care AI worse.Guest:Nicholson Price, JD, PhD, Professor of Law, University of MichiganLearn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

With high health bills drowning patients in debt, some lawmakers want nonprofit hospitals to give away more free care. But experts warn that could wind up being worse for patients. Guests:Ge Bai, PhD, CPA, Professor of Accounting at Carey Business School, Professor of Health Policy at Bloomberg School of Public Health at Johns Hopkins University Jill Horwitz, PhD, JD, MPP, David Sanders Professor of Law and Medicine and Founding Faculty Director, Lowell Milken Center for Philanthropy and Nonprofits, UCLADonna Lynne, DrPH, Denver Health CEOBruce Siegel, MD, MPH, President and CEO of America’s Essential HospitalsGary Young, PhD, JD, Director of the Center for Health Policy and Healthcare Research at Northeastern University Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

A handful of states allow terminally ill people to take life-ending medications prescribed by a doctor instead of waiting for death. This week, we talk with journalist Steven Petrow about his sister’s choice to use medical aid in dying.Guest:Steven Petrow, Journalist and author Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Companies claim they can catch cancer sooner with new blood tests and full-body MRI scans. What are the risks and benefits?Guest: Ishani Ganguli, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; primary care physician, Brigham and Women's HospitalLearn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

A live conversation between a top federal health official and a health care executive about how they must work together to keep AI from exacerbating racial bias in health care.Guests:Micky Tripathi, PhD, MPP, National Coordinator for Health Information Technology, U.S. Department of Health and Human ServicesJames Ellzy, MD, Chief Health Officer, Oracle Health Government ServicesLearn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Key court decisions in 2024 about prescription drug prices, abortion bans, gender affirming care and the Affordable Care Act could change the way health care is delivered in America. Guests:Zach Baron, Co-director of Health Policy and the Law Initiative, O’Neill Institute for National and Global Health at Georgetown University Law CenterKatie Eyer, Professor at Rutgers Law School Laurie Sobel, Associate Director of Women's Health Policy at KFF Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Fentanyl killed 75,000 people in 2022. Now it’s making one of the few treatments for opioid addiction harder to use.Guests:Eric Ezzi, Certified Recovery Specialist, Penn MedicineAshish Thakrar, MD, Assistant Professor of Medicine, University of PennsylvaniaLeslie Suen, MD, Assistant Professor of Medicine, University of California San FranciscoRyan Levi, Reporter/Producer, Tradeoffs Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

We've got a lot to share with you in 2024!We're looking into how fentanyl and other synthetic opioids are upending long established treatments for opioid addiction, and what clinicians and policymakers are doing to adapt.There are a bunch of cases in the courts this year that have the potential to change Americans' access to care, and restrict the power of federal health agencies.And nearly 25 years after a landmark case, declaring that people with intellectual and developmental disabilities have a right to live outside state-run institutions, we examine how doctors, hospitals and insurers are failing many of them … and one woman's work to forge a better path.New episodes start 25 January, 2024!Sign up for our weekly newsletter.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Last fall, the federal government named its first 10 targets for historic drug price negotiations with big pharma. Those negotiations are expected to heat up this February when federal officials make their opening price offers.This week, we offer a refresher on how this negotiation process will work and the impact it could have.Guests:Anton Avanceña, PhD, Assistant Professor of Health Outcomes, University of Texas Darius Lakdawalla, PhD, Professor of Pharmaceutical Economics and Public Policy, University of Southern California Lauren Neves, JD, Deputy Vice President, PhRMASteve Pearson, MD, MSc, Founder and President, Institute for Clinical and Economic Review (ICER)Ben Rome, MD, MPH, physician and researcher, Harvard Medical SchoolMeena Seshamani, MD, PhD, Deputy Administrator, Centers for Medicare and Medicaid ServicesLeslie Walker, Senior Producer/Reporter, TradeoffsLearn more and read a full transcript on our website.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.